Middle Aortic Syndrome Presented in Pregnancy-Treated with Percutaneous Intervention Followed by Successful Management of the Complications

Introduction: Mid-aortic syndrome is a clinical condition characterized by segmental narrowing of the abdominal or descending thoracic aorta, often resulting in severe hypertension. It can manifest as either a congenital abnormality or as one of several acquired conditions. Given the limited evidence available on the treatment of this syndrome, various approaches have been reported, including surgical intervention and endovascular treatments such as stent placement and medical management alone. Objective: To determine the prevalence of ACS patients and the risk factors of in-hospital mortality of STEMI patients at Bekasi District General Hospital in 2021. Case presentation: We present the case of a 21-year-old female who developed life-threatening hypertension during the 21st week of pregnancy, a condition that went unrecognized before gestation due to the rarity of this syndrome. Unfortunately, in our patient, arterial hypertension proved resistant to a 4-drug antihypertensive regimen and there is evidence of end organ damage and fetal compromise. However following termination of pregnancy, a successful endovascular repair of mid-aortic syndrome was achieved using a self-expanding stent, along with bilateral renal artery stenting. Following the procedure, patient developed haemorrhagic stroke which was managed successfully and patient discharged in a stable condition. Conclusion: Patient is doing well for the last 11 months. Mid-aortic syndrome presented in pregnancy can be successfully managed with percutaneous intervention.